Five years after proposing a rule that would have given generic drug makers responsibility for their own drug labels—a move that would have exposed them to more lawsuits—the FDA has changed its mind.
Five years after proposing a rule that would have given generic drug makers responsibility for their own drug labels—a move that would have exposed them to more lawsuits—the FDA has changed its mind.
Dr Scott Gottlieb highlighted how brand reference drug companies voluntarily withdraw their marketing applications and stopped updating their labelling…